Report Detail

Medical Devices & Consumables Laparoscopic Instruments - Medical Devices Pipeline Assessment, 2019

  • RnM2890061
  • |
  • 06 February, 2019
  • |
  • Global
  • |
  • 73 Pages
  • |
  • GlobalData
  • |
  • Medical Devices & Consumables

Laparoscopic Instruments - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Laparoscopic Instruments - Medical Devices Pipeline Assessment, 2019" provides an overview of Laparoscopic Instruments currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Laparoscopic Instruments pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Laparoscopic Instruments under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Laparoscopic Instruments and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry.

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Laparoscopic Instruments under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date.


1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Laparoscopic Instruments Overview

3 Products under Development

  • 3.1 Laparoscopic instruments - Pipeline Products by Stage of Development
  • 3.2 Laparoscopic instruments - Pipeline Products by Territory
  • 3.3 Laparoscopic instruments - Pipeline Products by Regulatory Path
  • 3.4 Laparoscopic instruments - Pipeline Products by Estimated Approval Date

4 Laparoscopic instruments - Pipeline Products under Development by Companies

  • 4.1 Laparoscopic instruments Companies - Pipeline Products by Stage of Development
  • 4.2 Laparoscopic instruments - Pipeline Products by Stage of Development

5 Laparoscopic instruments Companies and Product Overview

  • 5.1 Adroit Motion LLC Company Overview
  • 5.2 Agile EndoSurgery Inc Company Overview
  • 5.3 Alesi Surgical Ltd Company Overview
  • 5.4 Cornell University Company Overview
  • 5.5 De La Salle University Medical Center Company Overview
  • 5.6 Genicon Inc Company Overview
  • 5.7 Janus Development Group Inc Company Overview
  • 5.8 MedInno Mobile LLC Company Overview
  • 5.9 Miret Surgical Inc Company Overview
  • 5.10 neoSurgical Ltd Company Overview
  • 5.11 Teijin Pharma Ltd Company Overview
  • 5.12 University of Missouri Company Overview
  • 5.13 University of Nebraska Company Overview
  • 5.14 University of South Florida Company Overview
  • 5.15 University of Utah Company Overview
  • 5.16 Vanderbilt University Company Overview

6 Laparoscopic instruments- Recent Developments

  • 6.1 Jul 10, 2018: Stryker announces organizational changes
  • 6.2 Jun 20, 2018: Positive Results from Mayo Clinic Sponsored Prospective Multi-center Trial in Lung Transplant Patients
  • 6.3 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value
  • 6.4 May 31, 2018: Merit Medical Announces Leadership Change and Appointment of Interim CFO
  • 6.5 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results
  • 6.6 May 17, 2018: Change in the Executive Management at Richard Wolf
  • 6.7 May 11, 2018: Teleflex: Reaffirms 2018 Guidance and Provides 3-Year Financial Goals and Objectives
  • 6.8 May 09, 2018: Teijin: Consolidated Financial Statements Summary For the year ended March 31, 2018
  • 6.9 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
  • 6.10 May 07, 2018: Integra LifeSciences Announces Amendment and Extension of Credit Facility
  • 6.11 May 03, 2018: Teleflex Reports First Quarter 2018 Results
  • 6.12 Apr 26, 2018: Stryker reports first quarter 2018 operating results
  • 6.13 Apr 25, 2018: Merit Medical Reports First Quarter of 2018 Financial Results
  • 6.14 Apr 25, 2018: LeMaitre Q1 2018 Sales $26.0mm (+8%), EPS $0.19 (+17%)
  • 6.15 Apr 25, 2018: CONMED Announces First Quarter 2018 Financial Results
  • 6.16 Apr 12, 2018: Mauna Kea Technologies’ Cellvizio Demonstrates Superior Identification of Patients at Risk for Esophageal Cancer Compared to Current Diagnostic Standard
  • 6.17 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
  • 6.18 Apr 03, 2018: In Vivo Confocal Laser Endomicroscopy with Cellvizio allows the discovery of a previously unknown human structure, the interstitium
  • 6.19 Mar 22, 2018: Human Xtensions Receives FDA Clearance for Its HandX, the First in a Line of Smart Digital Handtop Solutions
  • 6.20 Mar 16, 2018: Cellvizio Obtains Positive Assessment from the Korean National Evidence-based healthcare Collaborating Agency (NECA)
  • 6.21 Mar 13, 2018: Surgical Innovations Group: Final results for the year ended 31 December 2017
  • 6.22 Feb 28, 2018: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2017; Merit Meets Range of 2017 Guidance; Gives 2018 Guidance
  • 6.23 Feb 27, 2018: Integra LifeSciences Reports Fourth Quarter and Full-Year 2017 Financial Results
  • 6.24 Feb 27, 2018: Titan Medical Granted Patent Related to Instrument End-Effector for Use in Robotic Surgery
  • 6.25 Feb 22, 2018: Teleflex Reports Fourth Quarter and Full Year 2017 Results; Provides 2018 Guidance
  • 6.26 Feb 21, 2018: LeMaitre Reports Net Income Of $4.3mm In Q4 2017
  • 6.27 Jan 31, 2018: CONMED Announces Fourth Quarter and Fiscal Year 2017 Financial Results
  • 6.28 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
  • 6.29 Jan 30, 2018: Stryker reports 2017 results and 2018 outlook

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us

Summary:
Get latest Market Research Reports on Laparoscopic Instruments . Industry analysis & Market Report on Laparoscopic Instruments is a syndicated market report, published as Laparoscopic Instruments - Medical Devices Pipeline Assessment, 2019. It is complete Research Study and Industry Analysis of Laparoscopic Instruments market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$2,500.00
$5,000.00
$7,500.00
1,965.00
3,930.00
5,895.00
2,362.50
4,725.00
7,087.50
388,000.00
776,000.00
1,164,000.00
211,100.00
422,200.00
633,300.00
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report